| Patent | Date |
|---|
Pyrimidine compound as JAK kinase inhibitor
Grant 11,420,965 - Kozak , et al. August 23, 2 | 2022-08-23 |
System And Method For Creating And Managing Actionable Data
App 20220237198 - Luttich; Jaron ; et al. | 2022-07-28 |
System And Method For Identifying And Extracting Information
App 20220237221 - Luttich; Jaron ; et al. | 2022-07-28 |
Compounds and methods for modulating Bruton's Tyrosine Kinase
Grant 11,306,099 - Hudson , et al. April 19, 2 | 2022-04-19 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20220017485 - Beausoleil; Anne-Marie ; et al. | 2022-01-20 |
Pyrimidine compounds as JAK kinase inhibitors
Grant 11,110,095 - Hudson , et al. September 7, 2 | 2021-09-07 |
Pyrimidine Compound As Jak Kinase Inhibitor
App 20210214349 - Kozak; Jennifer ; et al. | 2021-07-15 |
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20210179637 - Hudson; Ryan ; et al. | 2021-06-17 |
Prodrugs of a JAK Inhibitor Compound for Treatment of Gastrointestinal Inflammatory Disease
App 20210179655 - Hudson; Ryan ; et al. | 2021-06-17 |
Compounds and methods for modulating interleukin-2-inducible t-cell kinase
Grant 11,008,314 - Hudson , et al. May 18, 2 | 2021-05-18 |
Pyrimidine compound as JAK kinase inhibitor
Grant 10,988,470 - Kozak , et al. April 27, 2 | 2021-04-27 |
Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,981,892 - Beausoleil , et al. April 20, 2 | 2021-04-20 |
Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
Grant 10,961,267 - Hudson , et al. March 30, 2 | 2021-03-30 |
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-- yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
Grant 10,947,254 - Hudson , et al. March 16, 2 | 2021-03-16 |
Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20210070788 - Beausoleil; Anne-Marie ; et al. | 2021-03-11 |
Phosphonamidates that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20200399259 - Beausoleil; Anne-Marie ; et al. | 2020-12-24 |
Compounds and methods for modulating bruton's tyrosine kinase
Grant 10,870,652 - Hudson , et al. December 22, 2 | 2020-12-22 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20200392105 - Beausoleil; Anne-Marie ; et al. | 2020-12-17 |
Pyrimidine Compound As Jak Kinase Inhibitor
App 20200369660 - KOZAK; JENNIFER ; et al. | 2020-11-26 |
Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways for Selective Removal of Senescent Cells in the Treatment of Age Related Conditions
App 20200360386 - Hudson; Ryan ; et al. | 2020-11-19 |
Treatment of Lung Diseases Using Pharmaceutical Agents that Eliminate Senescent Cells
App 20200354336 - Vlahakis; Nick ; et al. | 2020-11-12 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20200317640 - Beausoleil; Anne-Marie ; et al. | 2020-10-08 |
Pyrimidine compound as JAK kinase inhibitor
Grant 10,774,080 - Kozak , et al. September 15, 2 | 2020-09-15 |
Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,745,429 - Beausoleil , et al. A | 2020-08-18 |
Glucuronide prodrugs of Janus kinase inhibitors
Grant 10,745,405 - Long , et al. A | 2020-08-18 |
Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,738,042 - Beausoleil , et al. A | 2020-08-11 |
Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,717,722 - Beausoleil , et al. | 2020-07-21 |
Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,703,745 - Beausoleil , et al. | 2020-07-07 |
Treatment of Lung Diseases Using Pharmaceutical Agents that Eliminate Senescent Cells
App 20200199103 - Vlahakis; Nick ; et al. | 2020-06-25 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
Grant 10,689,416 - Hudson , et al. | 2020-06-23 |
Pyrimidine Compound As Jak Kinase Inhibitor
App 20200140430 - KOZAK; JENNIFER ; et al. | 2020-05-07 |
Pyrimidine compound as JAK kinase inhibitor
Grant 10,562,894 - Kozak , et al. Feb | 2020-02-18 |
Pyrimidine Compounds As Jak Kinase Inhibitors
App 20200046709 - Hudson; Ryan ; et al. | 2020-02-13 |
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20200040010 - Hudson; Ryan ; et al. | 2020-02-06 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
App 20200002378 - Hudson; Ryan ; et al. | 2020-01-02 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
Grant 10,519,197 - Hudson , et al. Dec | 2019-12-31 |
Prodrugs of a JAK Inhibitor Compound for Treatment of Gastrointestinal Inflammatory Disease
App 20190389895 - Hudson; Ryan ; et al. | 2019-12-26 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent C
App 20190382371 - Beausoleil; Anne-Marie ; et al. | 2019-12-19 |
Compounds And Methods For Modulating Interleukin-2-inducible T-cell Kinase
App 20190375743 - HUDSON; Ryan ; et al. | 2019-12-12 |
Acyl Phosphonamidates and Acyl Benzylamines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused
App 20190367496 - Beausoleil; Anne-Marie ; et al. | 2019-12-05 |
Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cell
App 20190330250 - Beausoleil; Anne-Marie ; et al. | 2019-10-31 |
Phosphonamidates that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer
App 20190330199 - Beausoleil; Anne-Marie ; et al. | 2019-10-31 |
Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
Grant 10,435,428 - Hudson , et al. O | 2019-10-08 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
App 20190248837 - Hudson; Ryan ; et al. | 2019-08-15 |
Pyrimidine Compound As Jak Kinase Inhibitor
App 20190241555 - KOZAK; JENNIFER ; et al. | 2019-08-08 |
Pyrimidine compound as JAK kinase inhibitor
Grant 10,308,646 - Kozak , et al. | 2019-06-04 |
Pyrimidine Compound As Jak Kinase Inhibitor
App 20190127364 - KOZAK; JENNIFER ; et al. | 2019-05-02 |
Compounds And Methods For Modulating Bruton's Tyrosine Kinase
App 20190106423 - HUDSON; Ryan ; et al. | 2019-04-11 |
Glucuronide Prodrugs Of Janus Kinase Inhibitors
App 20180339990 - LONG; DANIEL D. ; et al. | 2018-11-29 |
Pyrimidine compounds as JAK kinase inhibitors
Grant 10,028,960 - Hudson , et al. July 24, 2 | 2018-07-24 |
Neprilysin inhibitors
Grant 9,873,696 - Smith , et al. January 23, 2 | 2018-01-23 |
Pyrimidine Compounds As Jak Kinase Inhibitors
App 20170312280 - Hudson; Ryan ; et al. | 2017-11-02 |
Substituted naphthyridines as JAK kinase inhibitors
Grant 9,725,470 - Hudson , et al. August 8, 2 | 2017-08-08 |
Neprilysin Inhibitors
App 20170217959 - Smith; Cameron ; et al. | 2017-08-03 |
Prodrugs of a JAK Inhibitor Compound for Treatment of Gastrointestinal Inflammatory Disease
App 20170145044 - Hudson; Ryan ; et al. | 2017-05-25 |
Neprilysin inhibitors
Grant 9,555,041 - Smith , et al. January 31, 2 | 2017-01-31 |
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20160347772 - Hudson; Ryan ; et al. | 2016-12-01 |
Neprilysin Inhibitors
App 20160184316 - Smith; Cameron ; et al. | 2016-06-30 |
Dual-acting benzoimidazole antihypertensive agents
Grant 9,198,899 - Allegretti , et al. December 1, 2 | 2015-12-01 |
Dual-acting oxazole antihypertensive agents
Grant 9,181,206 - Fatheree , et al. November 10, 2 | 2015-11-10 |
Neprilysin inhibitors
Grant 9,120,758 - Smith , et al. September 1, 2 | 2015-09-01 |
Dual-acting pyrazole antihypertensive agents
Grant 8,822,522 - Blair , et al. September 2, 2 | 2014-09-02 |
Dual-acting Oxazole Antihypertensive Agents
App 20140194426 - Fatheree; Paul R. ; et al. | 2014-07-10 |
Dual-acting antihypertensive agents
Grant 8,735,625 - Choi , et al. May 27, 2 | 2014-05-27 |
Dual-acting Benzoimidazole Antihypertensive Agents
App 20140107120 - Allegretti; Paul ; et al. | 2014-04-17 |
Dual-acting Antihypertensive Agents
App 20140046075 - Choi; Seok-ki ; et al. | 2014-02-13 |
Dual-acting benzoimidazole antihypertensive agents
Grant 8,637,676 - Allegretti , et al. January 28, 2 | 2014-01-28 |
Neprilysin Inhibitors
App 20140011997 - Smith; Cameron ; et al. | 2014-01-09 |
Dual-acting oxazole antihypertensive agents
Grant 8,598,170 - Fatheree , et al. December 3, 2 | 2013-12-03 |
Neprilysin inhibitors
Grant 8,563,512 - Smith , et al. October 22, 2 | 2013-10-22 |
Dual-acting Pyrazole Antihypertensive Agents
App 20130245041 - Blair; Brooke ; et al. | 2013-09-19 |
Dual-acting Oxazole Antihypertensive Agents
App 20130196997 - Fatheree; Paul R. ; et al. | 2013-08-01 |
Dual-acting antihypertensive agents
Grant 8,394,846 - Choi , et al. March 12, 2 | 2013-03-12 |
Dual-acting oxazole antihypertensive agents
Grant 8,372,984 - Fatheree , et al. February 12, 2 | 2013-02-12 |
Dual-acting pyrazole antihypertensive agents
Grant 8,350,027 - Blair , et al. January 8, 2 | 2013-01-08 |
Dual-acting Pyrazole Antihypertensive Agents
App 20120259113 - Blair; Brooke ; et al. | 2012-10-11 |
Dual-acting antihypertensive agents
Grant 8,236,839 - Choi , et al. August 7, 2 | 2012-08-07 |
Neprilysin Inhibitors
App 20120157386 - SMITH; Cameron ; et al. | 2012-06-21 |
Dual-acting Antihypertensive Agents
App 20120129900 - CHOI; Seok-Ki ; et al. | 2012-05-24 |
Dual-acting Antihypertensive Agents
App 20120088919 - CHOI; Seok-Ki ; et al. | 2012-04-12 |
Dual-acting antihypertensive agents
Grant 8,143,298 - Choi , et al. March 27, 2 | 2012-03-27 |
Dual-acting pyrazole antihypertensive agents
Grant 8,119,634 - Blair , et al. February 21, 2 | 2012-02-21 |
Dual-acting antihypertensive agents
Grant 8,106,082 - Choi , et al. January 31, 2 | 2012-01-31 |
Dual-acting Pyrazole Antihypertensive Agents
App 20110275634 - Blair; Brooke ; et al. | 2011-11-10 |
Dual-acting pyrazole antihypertensive agents
Grant 7,956,054 - Blair , et al. June 7, 2 | 2011-06-07 |
Dual-acting Antihypertensive Agents
App 20110021585 - CHOI; Seok-Ki ; et al. | 2011-01-27 |
Dual-acting Oxazole Antihypertensive Agents
App 20110021527 - FATHEREE; Paul R. ; et al. | 2011-01-27 |
Dual-acting Pyrazole Antihypertensive Agents
App 20110009409 - Blair; Brooke ; et al. | 2011-01-13 |
Dual-acting antihypertensive agents
Grant 7,834,041 - Choi , et al. November 16, 2 | 2010-11-16 |
Dual-acting Antihypertensive Agents
App 20100267788 - CHOI; Seok-Ki ; et al. | 2010-10-21 |
Dual-acting antihypertensive agents
Grant 7,777,077 - Choi , et al. August 17, 2 | 2010-08-17 |
Dual-acting antihypertensive agents
App 20090093417 - Choi; Seok-Ki ; et al. | 2009-04-09 |
Dual-acting benzoimidazole antihypertensive agents
App 20080318951 - Allegretti; Paul ; et al. | 2008-12-25 |
Dual-acting antihypertensive agents
App 20080188533 - Choi; Seok-Ki ; et al. | 2008-08-07 |
| 